Highlight Capital USD Fund III Overview
- Fund Strategy
-
Venture
- Fund Status
-
Closed
- Fund Manager
- Highlight Capita...
- Size
-
$435M
- Vintage
-
2020
- Dry Powder
-
Highlight Capital USD Fund III General Information
Description
Highlight Capital USD Fund III is a 2020 vintage venture capital fund managed by Highlight Capital. The fund is located in Shanghai, China and invests in United States and China. The fund prefers healthcare sector.
Contact Information
Fund Manager's Location
- 3F/10F,F659 Building,No.659
- Fengyang Road
- Shanghai, 200041
- China
Highlight Capital USD Fund III Investments (24)
Highlight Capital USD Fund III has made a total of 24 investments. Its most recent deal was a with NeutanPharma for . The deal was made on 29-Mar-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| NeutanPharma | 29-Mar-2022 | Drug Discovery | Generating Revenue | |||
| MediLink Therapeutics | 01-Mar-2022 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Porotech | 18-Feb-2022 | General Purpose Semiconductors | Generating Revenue | |||
| BrioHealth Solutions | 25-Jan-2022 | Therapeutic Devices | Clinical Trials - General | |||
| Abmtx | 04-Jan-2022 | Drug Discovery | Generating Revenue | |||
| LePure (Other Devices and Supplies) | 01-Dec-2021 | Other Devices and Supplies | Generating Revenue | |||
| VelaVigo | 15-Nov-2021 | Biotechnology | Startup | |||
| AbogenBio | 23-Aug-2021 | Drug Discovery | Generating Revenue | |||
| Chaotianmen Pier | 05-Aug-2021 | Early Stage VC | Food Products | Generating Revenue | ||
| Ab&B Bio-Tech Co | 03-Aug-2021 | Later Stage VC (Series B) | Drug Discovery | Clinical Trials - General |
Highlight Capital USD Fund III Investment Strategy
Highlight Capital USD Fund III Limited Partners (1)
Highlight Capital is the sole limited partner of Highlight Capital USD Fund III. Its latest Original was on 01-Jan-2020.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| Highlight Capital | Current | 01-Jan-2020 | Original |
Highlight Capital USD Fund III Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
Highlight Capital USD Fund III Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
Highlight Capital USD Fund III Benchmark (22)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Accel India VI | |||||
| Ping An Global Voyager Fund | |||||
| China Creation Ventures USD II | |||||
| IDG Breyer Capital Fund | 31-Mar-2026 | ||||
| Sequoia Capital India Venture Fund | |||||
| Caldera Pacific Fund I | |||||
| Highlight Capital USD Fund III | 30-Sep-2025 | ||||
| LC Fund VIII | |||||
| Hillhouse Venture Fund V | 31-Mar-2026 | ||||
| Shanghai Jiawo Wensheng QFLP Fund |
Highlight Capital USD Fund III FAQs
-
What is Highlight Capital USD Fund III?
Highlight Capital USD Fund III is a 2020 vintage venture capital fund managed by Highlight Capital.
-
Who manages Highlight Capital USD Fund III?
Highlight Capital USD Fund III is managed by Highlight Capital.
-
Where is Highlight Capital USD Fund III domiciled?
Highlight Capital USD Fund III is domiciled in China.
-
What is Highlight Capital USD Fund III's size?
Highlight Capital USD Fund III has a size of $435M.
-
What type of fund is Highlight Capital USD Fund III?
The fund type of Highlight Capital USD Fund III is Venture.
-
What is the status of Highlight Capital USD Fund III?
Highlight Capital USD Fund III is closed.
-
What has Highlight Capital USD Fund III invested in?
Highlight Capital USD Fund III has made numerous investments in companies like NeutanPharma, MediLink Therapeutics, and Porotech within the Drug Discovery and General Purpose Semiconductors industries.
-
What has Highlight Capital USD Fund III invested in recently?
Highlight Capital USD Fund III's latest investment was on 29-Mar-2022 in NeutanPharma, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process